Table 2 Unadjusted and adjusted Odds ratios of malaria, ITNs and drug use before and during the Covid-19 epidemic phase
Crude OR[95%CI] | p | adjusted OR[95%CI] | p | |
|---|---|---|---|---|
Malaria | ||||
2019 | Ref | Ref | ||
2020 | 1.58 [1.36–1.83] | < 0.01 | 1.55 [1.34–1.79] | < 0.01 |
2021 | 1.50 [1.31–1.71] | < 0.01 | 1.43 [1.26–1.64] | < 0.01 |
2022 | 2.37 [2.09–2.70] | < 0.01 | 2.28 [2.01–2.59] | < 0.01 |
Antimalarial drug self-medication | ||||
2019 | Ref | Ref | ||
2020 | 2.23 [1.88–2.66] | < 0.01 | 2.18 [1.84–2.59] | < 0.01 |
2021 | 2.46 [2.10–2.87] | < 0.01 | 2.39 [2.05–2.79] | < 0.01 |
2022 | 2.37 [2.09–2.70] | < 0.01 | 1.97 [1.69–2.29] | < 0.01 |
ITN use | ||||
2019 | Ref | Ref | ||
2020 | 0.85 [0.75–0.97] | < 0.03 | 0.87 [0.76–0.98] | < 0.01 |
2021 | 0.69 [0.63–0.79] | < 0.01 | 0.72 [0.65–0.81] | < 0.01 |
2022 | 0.78 [0.70–0.87] | < 0.01 | 0.80 [0.71–0.89] | < 0.01 |